Aurobindo Pharma Limited (AUROPHARMA.BO)
INR 1264.95
(1.37%)
INR 1264.95
(1.37%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 287.04 Billion INR | 17.81% |
| 2022 | 246.17 Billion INR | 5.35% |
| 2021 | 233.66 Billion INR | -4.85% |
| 2020 | 245.57 Billion INR | 8.0% |
| 2019 | 227.37 Billion INR | 18.27% |
| 2018 | 192.25 Billion INR | 18.68% |
| 2017 | 161.99 Billion INR | 10.47% |
| 2016 | 146.63 Billion INR | 8.24% |
| 2015 | 135.47 Billion INR | 12.5% |
| 2014 | 120.42 Billion INR | 49.81% |
| 2013 | 80.38 Billion INR | 39.01% |
| 2012 | 57.82 Billion INR | 26.99% |
| 2011 | 45.53 Billion INR | 5.24% |
| 2010 | 43.27 Billion INR | 21.02% |
| 2009 | 35.75 Billion INR | 16.19% |
| 2008 | 30.77 Billion INR | 26.09% |
| 2007 | 24.4 Billion INR | 14.96% |
| 2006 | 21.22 Billion INR | 33.21% |
| 2005 | 15.93 Billion INR | 20.58% |
| 2004 | 13.21 Billion INR | -12.16% |
| 2003 | 15.04 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 75.67 Billion INR | -0.17% |
| 2023 Q3 | 72.71 Billion INR | 1.69% |
| 2023 Q1 | 67.9 Billion INR | 6.46% |
| 2023 Q2 | 71.5 Billion INR | 5.3% |
| 2023 FY | 290.01 Billion INR | 17.81% |
| 2023 Q4 | 75.8 Billion INR | 4.25% |
| 2022 Q3 | 63.87 Billion INR | 12.59% |
| 2022 Q2 | 56.73 Billion INR | -8.15% |
| 2022 Q1 | 61.76 Billion INR | 6.58% |
| 2022 FY | 246.17 Billion INR | 5.35% |
| 2022 Q4 | 63.78 Billion INR | -0.15% |
| 2021 Q1 | 56.91 Billion INR | -5.0% |
| 2021 Q4 | 57.95 Billion INR | -3.24% |
| 2021 Q3 | 59.89 Billion INR | 1.69% |
| 2021 FY | 233.66 Billion INR | -4.85% |
| 2021 Q2 | 58.89 Billion INR | 3.48% |
| 2020 FY | 245.57 Billion INR | 8.0% |
| 2020 Q3 | 63.53 Billion INR | -0.39% |
| 2020 Q2 | 63.77 Billion INR | 9.3% |
| 2020 Q1 | 58.35 Billion INR | -3.76% |
| 2020 Q4 | 59.91 Billion INR | -5.69% |
| 2019 Q2 | 55.18 Billion INR | 3.01% |
| 2019 Q4 | 60.63 Billion INR | 4.55% |
| 2019 FY | 227.37 Billion INR | 18.27% |
| 2019 Q1 | 53.56 Billion INR | 8.12% |
| 2019 Q3 | 57.99 Billion INR | 5.1% |
| 2018 Q2 | 47.51 Billion INR | 11.79% |
| 2018 Q4 | 49.54 Billion INR | -4.26% |
| 2018 FY | 192.25 Billion INR | 18.68% |
| 2018 Q1 | 42.5 Billion INR | 4.97% |
| 2018 Q3 | 51.75 Billion INR | 8.92% |
| 2017 Q3 | 43.36 Billion INR | -2.25% |
| 2017 FY | 161.99 Billion INR | 10.47% |
| 2017 Q4 | 40.49 Billion INR | -6.62% |
| 2017 Q2 | 44.35 Billion INR | 20.58% |
| 2017 Q1 | 36.78 Billion INR | 1.02% |
| 2016 Q4 | 36.41 Billion INR | -6.77% |
| 2016 Q1 | 37.66 Billion INR | 0.55% |
| 2016 FY | 146.63 Billion INR | 8.24% |
| 2016 Q2 | 37.75 Billion INR | 0.24% |
| 2016 Q3 | 39.06 Billion INR | 3.46% |
| 2015 FY | 135.47 Billion INR | 12.5% |
| 2015 Q4 | 37.45 Billion INR | 6.86% |
| 2015 Q3 | 35.05 Billion INR | 4.17% |
| 2015 Q2 | 33.65 Billion INR | 2.01% |
| 2015 Q1 | 32.98 Billion INR | 6.95% |
| 2014 Q3 | 31.66 Billion INR | 9.89% |
| 2014 Q4 | 30.84 Billion INR | -2.58% |
| 2014 FY | 120.42 Billion INR | 49.81% |
| 2014 Q1 | 29.11 Billion INR | 28.32% |
| 2014 Q2 | 28.81 Billion INR | -1.03% |
| 2013 Q3 | 21.4 Billion INR | 11.85% |
| 2013 FY | 80.38 Billion INR | 39.01% |
| 2013 Q2 | 19.13 Billion INR | 11.56% |
| 2013 Q1 | 17.15 Billion INR | 14.54% |
| 2013 Q4 | 22.68 Billion INR | 5.98% |
| 2012 Q3 | 15.7 Billion INR | 4.64% |
| 2012 Q2 | 15 Billion INR | 23.55% |
| 2012 Q4 | 14.97 Billion INR | -4.61% |
| 2012 FY | 57.82 Billion INR | 26.99% |
| 2012 Q1 | 12.14 Billion INR | 8.72% |
| 2011 Q3 | 12.84 Billion INR | 0.0% |
| 2011 FY | 45.53 Billion INR | 5.24% |
| 2011 Q4 | 11.17 Billion INR | -13.04% |
| 2010 FY | 43.27 Billion INR | 21.02% |
| 2009 FY | 35.75 Billion INR | 16.19% |
| 2008 FY | 30.77 Billion INR | 26.09% |
| 2007 FY | 24.4 Billion INR | 14.96% |
| 2006 FY | 21.22 Billion INR | 33.21% |
| 2005 FY | 15.93 Billion INR | 20.58% |
| 2004 FY | 13.21 Billion INR | -12.16% |
| 2003 FY | 15.04 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Ajanta Pharma Limited | 42.08 Billion INR | -582.026% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | -6714.44% |
| Sigachi Industries Limited | 3.98 Billion INR | -7094.902% |
| Bal Pharma Limited | 3.39 Billion INR | -8361.923% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | -2140.964% |
| Medico Remedies Limited | 1.44 Billion INR | -19707.039% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -27411.861% |
| Venus Remedies Limited | 5.91 Billion INR | -4753.245% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -37896.407% |
| Alpa Laboratories Limited | 1.08 Billion INR | -26297.613% |
| Nectar Lifesciences Limited | 16.84 Billion INR | -1604.456% |
| Shilpa Medicare Limited | 11.51 Billion INR | -2392.569% |
| Aarti Drugs Limited | 25.28 Billion INR | -1035.204% |
| Lupin Limited | 200.1 Billion INR | -43.445% |
| Zydus Lifesciences Limited | 190.21 Billion INR | -50.906% |
| Windlas Biotech Limited | 6.3 Billion INR | -4449.366% |
| Suven Life Sciences Limited | 116.92 Million INR | -245386.577% |
| Eris Lifesciences Limited | 20.09 Billion INR | -1328.694% |
| Valiant Laboratories Limited | 1.82 Billion INR | -15666.748% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.84 Billion INR | -723.851% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | -2217.889% |
| Ipca Laboratories Limited | 76.22 Billion INR | -276.58% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | -3626.672% |
| Achyut Healthcare Limited | 61.36 Million INR | -467636.153% |
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 40.812% |
| Bajaj HealthCare Limited | 4.73 Billion INR | -5963.248% |
| RPG Life Sciences Limited | 5.82 Billion INR | -4831.621% |
| Mankind Pharma Limited | 103.34 Billion INR | -177.747% |
| Laurus Labs Limited | 50.01 Billion INR | -473.883% |
| Piramal Pharma Limited | 81.71 Billion INR | -251.29% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -10972.387% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | -170.659% |
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | -369.633% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | -142.989% |
| Unichem Laboratories Limited | 16.57 Billion INR | -1631.883% |
| Sequent Scientific Limited | 13.69 Billion INR | -1995.63% |
| Novartis India Limited | 3.35 Billion INR | -8466.717% |
| Wanbury Limited | 5.75 Billion INR | -4886.452% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | -2630.242% |
| Wockhardt Limited | 27.89 Billion INR | -929.204% |
| Themis Medicare Limited | 3.81 Billion INR | -7418.975% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -13653.821% |
| Jubilant Pharmova Limited | 67.02 Billion INR | -328.24% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | -1157.197% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | -2.823% |
| Divi's Laboratories Limited | 78.45 Billion INR | -265.895% |
| NATCO Pharma Limited | 40.02 Billion INR | -617.254% |
| Gufic Biosciences Limited | 8.06 Billion INR | -3458.413% |
| IOL Chemicals and Pharmaceuticals Limited | 21.18 Billion INR | -1254.65% |
| Ind-Swift Limited | 5.02 Billion INR | -5612.701% |
| Procter & Gamble Health Limited | 11.51 Billion INR | -2393.312% |
| FDC Limited | 19.42 Billion INR | -1377.372% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -56829.088% |
| Granules India Limited | 45.06 Billion INR | -536.977% |
| Medicamen Biotech Limited | 1.79 Billion INR | -15908.649% |
| Alkem Laboratories Limited | 126.67 Billion INR | -126.598% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | -2115.657% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -71597.977% |
| Brooks Laboratories Limited | 794.86 Million INR | -36012.603% |
| Megasoft Limited | 373.95 Million INR | -76659.646% |
| ZIM Laboratories Limited | 3.67 Billion INR | -7712.355% |
| Strides Pharma Science Limited | 40.51 Billion INR | -608.556% |
| Neuland Laboratories Limited | 15.58 Billion INR | -1741.708% |
| Morepen Laboratories Limited | 17.01 Billion INR | -1586.616% |
| Hikal Limited | 17.84 Billion INR | -1508.456% |
| Indoco Remedies Limited | 17.89 Billion INR | -1504.096% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | -1481.075% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -18494.309% |
| Mangalam Drugs & Organics Limited | 3.68 Billion INR | -7687.549% |
| Hester Biosciences Limited | 3.04 Billion INR | -9325.341% |